Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
International Journal of Environmental Research and Public Health · 29.08.2023 · 20 (17) · 6671
DOI: 10.3390/ijerph20176671 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 29.08.2023. Verfasst von Ema Schönberger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, University Hospital Osijek, 31000 Osijek, Croatia. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional project/Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek.
Abstract (Originalsprache)
Given that the increase in the aging population has grown into one of the largest public health issues, inflammation and oxidative stress, which are closely associated with the aging process, became a focus of recent research. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, a group of drugs initially developed as oral antidiabetics, have shown many beneficial effects over time, including improvement in renal function and cardioprotective effects. It has been shown that SGLT2 inhibitors, as a drug class, have an immunomodulatory and antioxidative effect, affecting endothelial function as well as metabolic parameters. Therefore, it is not surprising that various studies have investigated the potential mechanisms of action of SGLT2 inhibitors in age-related diseases. The proposed mechanisms by which SGLT2 inhibitors can achieve their anti-inflammatory effects include influence on AMPK/SIRT1/PGC-1α signaling, various cytokines, and the NLRP3 inflammasome. The antioxidative effect is related to their action on mitochondria and their influence on the signaling pathways of transforming growth factor β and nuclear erythroid 2-related factor 2/antioxidant response element. Also, SGLT2 inhibitors achieve their anti-inflammatory and antioxidative effects by affecting metabolic parameters, such as uric acid reduction, stimulation of ketogenesis, reduction of body weight, lipolysis, and epicardial fat tissue. Finally, SGLT2 inhibitors display anti-atherosclerotic effects that modulate inflammatory reactions, potentially resulting in improvement in endothelial function. This narrative review offers a complete and comprehensive overview of the possible pathophysiologic mechanisms of the SGLT2 inhibitors involved in the aging process and development of age-related disease. However, in order to use SGLT2 inhibitor drugs as an anti-aging therapy, further basic and clinical research is needed to elucidate the potential effects and complex mechanisms they have on inflammation processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, University Hospital Osijek, 31000 Osijek, Croatia.
- Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
- Department of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, Josipa Huttlera 4, 31000 Osijek, Croatia.
- Department for Cardiovascular Disease, University Hospital Osijek, 31000 Osijek, Croatia.
- Department of Internal Medicine and History of Medicine, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Josipa Huttlera 4, 31000 Osijek, Croatia.
- Department of Family Medicine, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Josipa Huttlera 4, 31000 Osijek, Croatia.
ORCID-Profile: Ljiljana Trtica Majnarić, Ines Bilić Ćurčić
Förderung
- Institutional project/Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek
Zitieren
APA
Schönberger, E., Mihaljević, V., Steiner, K., Šarić, S., Kurevija, T., Majnarić, L. T., Bilić Ćurčić, I., & Canecki-Varžić, S. (2023). Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging. International Journal of Environmental Research and Public Health, 20(17), 6671. https://doi.org/10.3390/ijerph20176671
Vancouver
Schönberger E, Mihaljević V, Steiner K, Šarić S, Kurevija T, Majnarić LT, et al. Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging. International Journal of Environmental Research and Public Health. 2023;20(17):6671. doi:10.3390/ijerph20176671
BibTeX
@article{Schnberger2023,
author = {Schönberger, Ema and Mihaljević, Vjera and Steiner, Kristina and Šarić, Sandra and Kurevija, Tomislav and Majnarić, Ljiljana Trtica and Bilić Ćurčić, Ines and Canecki-Varžić, Silvija},
title = {Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
volume = {20},
number = {17},
pages = {6671},
doi = {10.3390/ijerph20176671}
}
EUVIMED